Lynn M. Georgic - Concepedia

Author

Lynn M. Georgic

Pfizer (United States)

Also Known As

L M Georgic, L. GEORGIC, L. M. GEORGIC, L. M. Georgic, L.M Georgic, Lynn Georgic, Lynn M. Georgic

Publications

570

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)

About

Lynn M. Georgic is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	296
2	Biochemistry	5	5	282
3	Natural Sciences	2	2	125
4	Social Sciences	2	2	44
5	Neuroscience	2	2	44

Lynn M. Georgic

Publications

549

Citations

H-Index

Page 1

	Year	Citations
Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907. Thomas A. Pugsley, M. Duff Davis, Hyacinth C. Akunne, Journal of Pharmacology and Experimental Therapeutics	1995	201
Substituted [(4-Phenylpiperazinyl)- methyl]benzamides: Selective Dopamine D<sub>4</sub> Agonists Shelly A. Glase, Hyacinth C. Akunne, Lynn M. Georgic, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ChemistryPharmaceutical ScienceBiochemistry	1997	105
Differential interaction of β1- and β3-adrenergic receptors with Gi in rat adipocytes Robert G. MacKenzie, Lynn M. Georgic, James G. Granneman Cellular Signalling Molecular PharmacologyDifferential InteractionSignal TransductionMolecular PhysiologyBiochemistry	1994	102
Aminopyrimidines with High Affinity for Both Serotonin and Dopamine Receptors David J. Wustrow, Thomas R. Belliotti, Shelly A. Glase, Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryFunctional SelectivityMedicineMonoamine Neurotransmitters	1998	30
A Series of 6- and 7-Piperazinyl- and -Piperidinylmethylbenzoxazinones with Dopamine D4 Antagonist Activity: Discovery of a Potential Atypical Antipsychotic Agent Thomas R. Belliotti, David J. Wustrow, Wouter A. Brink, Journal of Medicinal Chemistry	1999	26
8-amino-6-(arylsulphonyl)-5-nitroquinolines: novel nonpeptide neuropeptide Y1 receptor antagonists Jon L. Wright, Gary L. Bolton, Mark W. Creswell, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineNeuropeptide ReceptorNeuropharmacologyPharmacotherapy	1996	25
Novel cyclohexyl amides as potent and selective D3 dopamine receptor ligands Thomas R. Belliotti, Suzanne R. Kesten, John R. Rubin, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryFunctional SelectivityMedicine	1997	20
Effects of the Dopamine D<sub>3</sub> Antagonist PD 58491 and Its Interaction with the Dopamine D<sub>3</sub> Agonist PD 128907 on Brain Dopamine Synthesis in Rat Steven Z. Whetzel, Yu Hsin Shih, Lynn M. Georgic, Journal of Neurochemistry	1997	15
CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects. M. Duff Davis, Hyacinth C. Akunne, Leonard W. Cooke, PubMed Dopamine Partial AgonistPotential Antipsychotic AgentPsychotropic MedicationPsychopharmacologyPharmacotherapy	1995	14
3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1<i>H</i>-indoles as Dopamine D2 Partial Agonists and Autoreceptor Agonists David J. Wustrow, William Smith, Ann E. Corbin, Journal of Medicinal Chemistry	1997	11

Page 1